NYSE:MCK - McKesson Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $328.69
Forecasted Upside: 1.96 %
Number of Analysts: 12
Breakdown:
0 Sell Ratings
2 Hold Ratings
10 Buy Ratings
0 Strong Buy Ratings

^$322.38 As of 07/5/2022 06:46 PM ET

▼ -7.15 (-2.17%)

1 month | 3 months | 12 months

Get New McKesson Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for MCK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MCK

^$328.69

▲ +1.96% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for McKesson in the last 3 months. The average price target is $328.69, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 1.96% upside from the last price of $322.38.

Current Consensus is Buy

The current consensus among 12 polled investment analysts is to buy stock in McKesson. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

1/11/2021

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/11/2021

0 strong buy ratings
8 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

7/10/2021

0 strong buy ratings
7 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

10/8/2021

0 strong buy ratings
11 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

1/6/2022

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/6/2022

0 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

6/5/2022

0 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

7/5/2022

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
6/7/2022	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$343.00 ➝ $378.00	Low
5/19/2022	UBS Group	Boost Price Target	Hold	$380.00	Low
5/11/2022	Credit Suisse Group	Boost Price Target		$333.00 ➝ $377.00	Low
5/10/2022	Deutsche Bank Aktiengesellschaft	Boost Price Target		$270.00 ➝ $343.00	Low
5/9/2022	Mizuho	Boost Price Target		$280.00 ➝ $331.00	Low
5/6/2022	Robert W. Baird	Boost Price Target		$352.00 ➝ $380.00	High
4/18/2022	Cowen	Boost Price Target		$325.00 ➝ $361.00	Low
4/18/2022	Cowen	Boost Price Target	Outperform	$325.00 ➝ $361.00	Low
4/12/2022	Morgan Stanley	Boost Price Target	Overweight	$292.00 ➝ $370.00	Low
4/1/2022	Credit Suisse Group	Initiated Coverage	Outperform	$333.00	Low
2/8/2022	UBS Group	Boost Price Target	Buy	$245.00 ➝ $303.00	Medium
2/7/2022	Mizuho	Boost Price Target	Neutral	$250.00 ➝ $280.00	High
2/4/2022	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$262.00 ➝ $270.00	Low
2/3/2022	Robert W. Baird	Boost Price Target		$312.00 ➝ $340.00	Low
1/7/2022	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$230.00 ➝ $333.00	High
12/20/2021	Mizuho	Boost Price Target	Neutral	$236.00 ➝ $250.00	Medium
12/17/2021	Morgan Stanley	Boost Price Target	Overweight	$252.00 ➝ $292.00	Medium
12/10/2021	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy ➝ Buy	$279.00 ➝ $262.00	Medium
12/9/2021	Bank of America	Boost Price Target	Buy ➝ Buy	$250.00 ➝ $265.00	Low
12/9/2021	Robert W. Baird	Boost Price Target	Outperform ➝ Outperform	$280.00 ➝ $300.00	High
12/9/2021	Mizuho	Boost Price Target	Neutral ➝ Neutral	$229.00 ➝ $236.00	High
12/9/2021	Barclays	Boost Price Target	Overweight ➝ Overweight	$270.00 ➝ $290.00	High
12/6/2021	Morgan Stanley	Boost Price Target	Overweight	$240.00 ➝ $250.00	Low
12/6/2021	Cowen	Boost Price Target	Outperform ➝ Outperform	$268.00 ➝ $300.00	High
11/8/2021	Argus	Boost Price Target	Buy	$230.00 ➝ $270.00	Low
11/8/2021	Credit Suisse Group	Boost Price Target	Neutral	$224.00 ➝ $230.00	Low
11/5/2021	Cowen	Boost Price Target	Outperform	$247.00 ➝ $268.00	Low
11/3/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$261.00 ➝ $279.00	High
11/3/2021	Mizuho	Boost Price Target	Neutral	$210.00 ➝ $229.00	High
11/2/2021	Evercore ISI	Boost Price Target	Outperform	$225.00 ➝ $230.00	High
11/2/2021	Bank of America	Boost Price Target	Buy	$237.00 ➝ $250.00	High
11/2/2021	Jefferies Financial Group	Boost Price Target	Buy	$270.00 ➝ $280.00	High
11/2/2021	Robert W. Baird	Boost Price Target	Outperform	$254.00 ➝ $260.00	High
11/2/2021	Barclays	Boost Price Target	Overweight	$255.00 ➝ $270.00	High
10/29/2021	Morgan Stanley	Boost Price Target	Overweight	$226.00 ➝ $240.00	Medium
8/9/2021	Credit Suisse Group	Boost Price Target	Neutral	$222.00 ➝ $224.00	Medium
8/5/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$237.00 ➝ $261.00	High
5/12/2021	Mizuho	Boost Price Target	Neutral	$190.00 ➝ $205.00	Low
5/10/2021	Credit Suisse Group	Boost Price Target	Neutral	$192.00 ➝ $222.00	Medium
5/7/2021	The Goldman Sachs Group	Boost Price Target	Buy	$231.00 ➝ $257.00	High
5/7/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$231.00 ➝ $237.00	High
3/30/2021	Argus	Upgrade	Hold ➝ Buy	$230.00	Low
3/2/2021	Cowen	Boost Price Target	Positive ➝ Outperform	$210.00 ➝ $224.00	Low
2/3/2021	Morgan Stanley	Boost Price Target	Overweight	$219.00 ➝ $226.00	Low
2/3/2021	Credit Suisse Group	Boost Price Target	Neutral	$178.00 ➝ $192.00	Low
2/3/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$222.00 ➝ $231.00	Low
2/3/2021	Mizuho	Boost Price Target	Neutral	$178.00 ➝ $190.00	Low
2/1/2021	Cowen	Boost Price Target	Outperform	$186.00 ➝ $210.00	Low
11/18/2020	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy		Low
11/13/2020	Mizuho	Boost Price Target	Neutral	$150.00 ➝ $178.00	Medium
11/5/2020	Credit Suisse Group	Boost Price Target	Neutral	$174.00 ➝ $178.00	Medium
11/4/2020	Morgan Stanley	Boost Price Target	Overweight	$204.00 ➝ $219.00	High
11/4/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$202.00 ➝ $222.00	High
11/2/2020	Barclays	Upgrade	Equal Weight ➝ Overweight	$166.00 ➝ $166.00	Medium
8/4/2020	JPMorgan Chase & Co.	Boost Price Target	Positive ➝ Overweight	$187.00 ➝ $198.00	Low
8/4/2020	Credit Suisse Group	Boost Price Target	Neutral	$160.00 ➝ $162.00	Low
8/4/2020	Morgan Stanley	Boost Price Target	Overweight	$194.00 ➝ $204.00	Medium
8/4/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$169.00 ➝ $202.00	Medium
7/8/2020	Guggenheim	Boost Price Target	Buy	$168.00 ➝ $175.00	Medium
6/15/2020	Morgan Stanley	Boost Price Target	Overweight	$163.00 ➝ $194.00	Medium
5/27/2020	Guggenheim	Boost Price Target	Buy	$147.00 ➝ $168.00	High
5/26/2020	UBS Group	Boost Price Target	Buy	$160.00 ➝ $165.00	Low
5/22/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$184.00	Low
5/22/2020	Morgan Stanley	Boost Price Target	Overweight	$150.00 ➝ $163.00	Low
5/21/2020	Cowen	Boost Price Target	Outperform	$174.00 ➝ $186.00	Low
5/21/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$173.00 ➝ $169.00	Low
5/21/2020	Mizuho	Boost Price Target	Neutral	$140.00 ➝ $147.00	Low
5/20/2020	Cfra	Lower Price Target	Buy	$179.00 ➝ $171.00	Medium
5/15/2020	UBS Group	Upgrade	Neutral ➝ Buy	$151.00 ➝ $160.00	High
4/22/2020	Credit Suisse Group	Initiated Coverage	Neutral	$146.00	Low
4/2/2020	Credit Suisse Group	Lower Price Target	Neutral	$155.00 ➝ $147.00	High
3/31/2020	Barclays	Lower Price Target	Equal Weight	$170.00 ➝ $163.00	Medium
3/27/2020	Morgan Stanley	Lower Price Target	Overweight	$182.00 ➝ $150.00	Low
3/18/2020	Credit Suisse Group	Reiterated Rating	Hold	$145.00	Medium
3/18/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$186.00 ➝ $187.00	High
3/18/2020	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$173.00 ➝ $174.00	High
3/13/2020	Guggenheim	Upgrade	Neutral ➝ Buy		Medium
3/6/2020	Morgan Stanley	Reiterated Rating	Buy	$182.00	Medium
2/11/2020	Morgan Stanley	Boost Price Target	Overweight	$168.00 ➝ $182.00	Medium
2/7/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$164.00 ➝ $197.00	Medium
2/5/2020	Robert W. Baird	Boost Price Target	Neutral	$161.00 ➝ $164.00	Medium
2/5/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$153.00 ➝ $173.00	Medium
2/5/2020	Morgan Stanley	Boost Price Target	Overweight	$162.00 ➝ $168.00	Medium
1/19/2020	Barclays	Reiterated Rating	Hold	$170.00	Low
1/15/2020	Mizuho	Boost Price Target	Neutral	$137.00 ➝ $140.00	High
1/10/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$135.00 ➝ $162.00	Medium
1/9/2020	UBS Group	Downgrade	Sell	$147.00	High
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$155.00	Medium
9/5/2019	Cleveland Research	Reiterated Rating	Hold		Low
8/27/2019	Morgan Stanley	Boost Price Target	Equal Weight	$130.00 ➝ $135.00	High
8/5/2019	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		Low
7/31/2019	Bank of America	Set Price Target	Buy	$160.00	N/A
7/22/2019	Credit Suisse Group	Initiated Coverage	Neutral	$143.00	Low
7/22/2019	Guggenheim	Initiated Coverage	Neutral ➝ Neutral	$152.00	Low
7/22/2019	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$164.00	Low
4/2/2019	Wolfe Research	Initiated Coverage	Outperform		High
2/1/2019	Barclays	Reiterated Rating	Hold	$130.00	Medium
1/25/2019	Deutsche Bank Aktiengesellschaft	Upgrade	Sell ➝ Hold	$175.00	Low
1/17/2019	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$134.00	Low
1/6/2019	Barclays	Reiterated Rating	Hold	$124.00	Low
12/9/2018	Morgan Stanley	Lower Price Target		$142.00 ➝ $130.00	Low
12/3/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$142.00 ➝ $130.00	Medium
10/26/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$150.00 ➝ $136.00	High
10/26/2018	Royal Bank of Canada	Set Price Target	Hold	$155.00	Medium
8/12/2018	Mizuho	Reiterated Rating	Hold	$133.00	High
7/27/2018	JPMorgan Chase & Co.	Lower Price Target	Overweight ➝ Overweight	$181.00 ➝ $160.00	Low
7/27/2018	Jefferies Financial Group	Reiterated Rating	Buy	$160.00	Medium
7/27/2018	Royal Bank of Canada	Reiterated Rating	Hold	$152.00	Medium
7/20/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral		Low
7/20/2018	Citigroup	Lower Price Target	Buy	$160.00 ➝ $2.86	Low
7/10/2018	Standpoint Research	Upgrade	Hold ➝ Buy		Low
7/3/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$175.00 ➝ $142.00	Low
6/29/2018	Royal Bank of Canada	Lower Price Target	Market Perform	$158.00	High
5/29/2018	SVB Leerink	Set Price Target	Market Perform ➝ Market Perform	$170.00 ➝ $160.00	High
4/11/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$179.00 ➝ $172.00	Low
3/8/2018	Barclays	Initiated Coverage	Equal Weight ➝ Equal Weight	$165.00	Medium
2/27/2018	Bank of America	Initiated Coverage	Buy ➝ Buy	$179.00	Low
2/2/2018	Credit Suisse Group	Reiterated Rating	Sell	$130.00	High
2/2/2018	Mizuho	Lower Price Target	Neutral ➝ Neutral	$186.00 ➝ $179.00	High
1/24/2018	Mizuho	Set Price Target	Hold	$186.00	Low
1/24/2018	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$205.00	High
1/23/2018	Needham & Company LLC	Boost Price Target	Buy ➝ Buy	$173.00 ➝ $180.00	Medium
1/17/2018	Robert W. Baird	Reiterated Rating	Buy	$200.00	Low
1/4/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$179.00	Low
12/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$175.00	High
11/9/2017	Credit Suisse Group	Reiterated Rating	Underperform	$155.00 ➝ $130.00	N/A
11/1/2017	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$178.00 ➝ $173.00	N/A
10/27/2017	Royal Bank of Canada	Reiterated Rating	Hold	$170.00	N/A
10/24/2017	Mizuho	Set Price Target	Hold	$168.00	N/A
10/24/2017	Needham & Company LLC	Set Price Target	Buy	$179.00 ➝ $178.00	N/A
10/18/2017	Jefferies Financial Group	Set Price Target	Hold	$165.00	N/A
10/16/2017	Needham & Company LLC	Set Price Target	Buy	$179.00	N/A
10/10/2017	Cowen	Upgrade	Market Perform ➝ Outperform	$176.00 ➝ $189.00	N/A
9/19/2017	Royal Bank of Canada	Initiated Coverage	Sector Perform ➝ Sector Perform	$168.00	Low
9/19/2017	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$175.00 ➝ $178.00	Low
9/14/2017	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$184.00 ➝ $172.00	High
9/8/2017	Needham & Company LLC	Upgrade	Hold ➝ Buy	$179.00	Low
8/29/2017	Jefferies Financial Group	Set Price Target	Hold	$165.00	Low
7/27/2017	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$153.00	Low

(Data available from 7/6/2017 forward)

News Sentiment Rating

0.56 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

5 very positive mentions
36 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

12/7/2021

11 very positive mentions
34 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

1/6/2022

6 very positive mentions
28 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

2/5/2022

11 very positive mentions
37 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

3/7/2022

6 very positive mentions
16 positive mentions
4 negative mentions
0 very negative mentions

Mentions as of

4/6/2022

4 very positive mentions
12 positive mentions
3 negative mentions
2 very negative mentions

Mentions as of

5/6/2022

7 very positive mentions
42 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

6/5/2022

12 very positive mentions
23 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

7/5/2022

Current Sentiment

Recent Stories by Sentiment

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $322.38

$316.56

$328.74

50 Day Range

MA: $320.36

$300.57

$336.42

52 Week Range

Now: $322.38

$186.61

$339.94

Volume

1,061,757 shs

Average Volume

1,200,116 shs

Market Capitalization

$46.29 billion

P/E Ratio

44.71

Dividend Yield

0.57%

Beta

0.63

Frequently Asked Questions

What sell-side analysts currently cover shares of McKesson?: The following Wall Street analysts have issued stock ratings on McKesson in the last twelve months: Argus, Bank of America Co., Barclays PLC, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., Mizuho, Morgan Stanley, Robert W. Baird, StockNews.com, TheStreet, and UBS Group AG.
View the latest analyst ratings for MCK.
What is the current price target for McKesson?: 0 Wall Street analysts have set twelve-month price targets for McKesson in the last year. Their average twelve-month price target is $328.69, suggesting a possible upside of 2.0%.
View the latest price targets for MCK.
What is the current consensus analyst rating for McKesson?: McKesson currently has 2 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MCK will outperform the market and that investors should add to their positions of McKesson.
View the latest ratings for MCK.
What other companies compete with McKesson?: Other companies that are similar to McKesson include AmerisourceBergen, Cardinal Health, Henry Schein, Patterson Companies and Owens & Minor. Learn More about companies similar to McKesson.
How do I contact McKesson's investor relations team?: McKesson's physical mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company's listed phone number is (972) 446-4800 and its investor relations email address is [email protected] The official website for McKesson is www.mckesson.com. Learn More about contacing McKesson investor relations.

NYSE:MCK - McKesson Stock Price Target and Predictions

Analyst Price Target for MCK

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.56 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of McKesson?

What is the current price target for McKesson?

What is the current consensus analyst rating for McKesson?

What other companies compete with McKesson?

How do I contact McKesson's investor relations team?